Also categorized in PubMed:
Treatment of chronic graft versus host disease with bortezomib.
x hide permanently

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study.

ncbi.nlm.nih.gov

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study.

Front Neurol. 2017;8:468

Authors: Pranzatelli MR, Tate ED, McGee NR

Abstract Pediatric-onset opsoclonus-myoclonus syndrome (OMS) is a devastating neuroinflammatory, often paraneoplastic, disorder. The objective was to characterize demographic, clinical, and immunologic aspects in the largest cohort reported to date.